Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. - sprookjes - yvandenbroek - TriplyDB

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

http://www.wikidata.org/entity/Q30422206

about

Cardiac cachexia: hic et nunc Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment Risk of chronic kidney disease after nephrectomy for renal cell carcinoma Latest consensus and update on protein-energy wasting in chronic kidney disease Pharmacokinetics of drugs in cachectic patients: a systematic review Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.Does serum albumin and creatinine predict survival of inpatient palliative care patients?Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors.Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.Mediterranean dietary quality index and dietary phytochemical index among patients candidate for coronary artery bypass grafting (CABG) surgery Body Composition Analysis Allows the Prediction of Urinary Creatinine Excretion and of Renal Function in Chronic Kidney Disease Patients Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention.Muscle wasting: an overview of recent developments in basic research.Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Cachexia as a major public health problem: frequent, costly, and deadly.Moving on up: the Journal of Cachexia, Sarcopenia and Muscle.Relationship between Stage of Chronic Kidney Disease and Sarcopenia in Korean Aged 40 Years and Older Using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011.Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients.Nutritional Competence and Resilience among Hemodialysis Patients in the Setting of Dialysis Initiation and Hospitalization Critical appraisal of biomarkers of dietary intake and nutritional status in patients undergoing dialysis.The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure.The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients.Variation in serum creatinine level is correlated to risk of type 2 diabetes.Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy.Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients.Sarcopenia among patients receiving hemodialysis: weighing the evidence.Timing of return to dialysis in patients with failing kidney transplants.Risk of chronic kidney disease after cancer nephrectomy.Sarcopenia in solid organ transplantation.Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients.The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management.Acute Kidney Injury: Diagnostic Approaches and Controversies Measurement of muscle mass in sarcopenia: from imaging to biochemical markers.Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients.Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?

P2860

Q26744140-A1184572-4037-4C02-937C-24438F6D8326 Q26775254-42D05CE5-723E-4B4C-8439-F378BE3D37B6 Q26862825-379637F2-C91E-4480-A95E-B8728460792F Q27027875-7F609397-C45A-4450-873E-C602ED5AF2D9 Q28535322-78DC5DDF-3A42-4C02-BD84-4BD934A0DC1C Q30488423-89007A05-705E-4347-A631-44550801C947 Q31128680-7DFCC7A2-BC0A-44C8-ACCD-9AA5E018F56F Q33610729-4BDC6F53-7E5C-4B13-B914-A55C59560F29 Q33645497-E530F483-75A9-42AA-AE08-BDDF8E91C94F Q33651687-3CA4C242-C422-4F5C-8E24-6B51AEC559C8 Q33851837-BB3F8C2D-8D38-4E5A-8B38-27979DFBD231 Q34156932-E99D1E8A-645D-4511-8AE8-D2C5187C204B Q34156942-E0D52F34-4FB4-46C4-8469-329F0B257DDD Q34334313-A96FB979-5CFD-42CC-95F5-9E7728EDF89D Q34335859-EF997AE1-0ABC-4218-8D8F-08670A6676C4 Q34495485-DEDE17EB-2576-4AF0-97B5-E3BF93266534 Q35666128-72DB0295-28A8-4998-804E-A5DE22B38EE6 Q35710756-C894AA77-0C4B-4725-BE07-93911DB9D239 Q35940980-B3BFEF85-D16F-41A2-A1A3-48207DC6222D Q36025639-51027021-8BAC-4499-BE2F-1346E0CD6CA2 Q36064124-E2BC8ADF-0126-465B-9656-B2B35917D712 Q36279259-47375F74-5243-43E9-BB40-B41B3B6103F4 Q36453374-7183FDA0-74B2-43EC-B886-05F51AF772D0 Q37050229-B66DAA06-D076-41F9-BE89-C2287D036985 Q37151558-1FCB21AE-00CC-4129-8944-258D8A4071A8 Q37264413-A364B50D-BF92-41EA-B525-A89057820F23 Q37510000-D4FD8FF3-666D-4B11-A98F-5A489AEE208E Q37540852-2B5C2F4D-A181-474F-848F-A4DFE7B6B056 Q37667482-60156453-CCB1-4599-9C28-2CCABE8D5A6D Q38135467-6B02B7FE-1814-410D-B3AC-2800FBFDC8D0 Q38178096-26CDF8E8-2876-46D1-8C36-35D3AD57C9E6 Q38188425-FFF2BFF1-9490-4E6D-B97A-B340613F4ECC Q38236547-31242377-7816-415C-B8FD-08ABF69636C8 Q38821770-EE138981-E1C0-4355-AB4F-58DD872B4158 Q39123320-40E9CACC-35FD-470D-8DE7-D9F9EDB2955D Q39125530-4326D83D-D44D-45E1-B59C-1121530B252D Q39413414-5D69FD33-740D-4620-B88B-749EB4FC01F9 Q39486839-9E8CC45B-F6DE-4879-8C34-52EB9F3AB558 Q40402171-78D8A602-E858-4223-BF36-C4EA8F99EE47 Q41829893-72DB6510-43F5-478C-A51E-2B21CBDD9AAF

P2860

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

http://www.wikidata.org/entity/Q30422206

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Serum creatinine as a marker o ...... tudy and review of literature.

@ast

Serum creatinine as a marker o ...... tudy and review of literature.

@en

type

label

Serum creatinine as a marker o ...... tudy and review of literature.

@ast

Serum creatinine as a marker o ...... tudy and review of literature.

@en

prefLabel

Serum creatinine as a marker o ...... tudy and review of literature.

@ast

Serum creatinine as a marker o ...... tudy and review of literature.

@en

P1433

Q30422206-BDE4A9BE-1840-47B8-BA09-3D20AE8CE07C

P1476

Q30422206-B2156872-43B9-418B-945D-0E7574E3DBEB

P2093

Q30422206-514F41A9-99B7-4C36-99A0-892D2259EBF6

Q30422206-5478912B-A569-43DA-9327-581878DACAA3

Q30422206-64AA8015-C70F-4695-9026-6B1B1C3922F6

Q30422206-8059FAE8-53C1-46EE-ADE7-E43D49694391

Q30422206-D6812478-5A2D-4EDD-B8AC-CDE1029973C3

P2860

Q30422206-09AFB921-B035-4EEB-89D2-745B6E038C64

Q30422206-1690FD24-3061-4BDE-B578-18E0A761B861

Q30422206-1C71BEB7-EC5A-4E78-8A9F-2A1870B4E0C8

Q30422206-224B1994-3C81-49BE-A46D-4B60466C37D4

Q30422206-37457FAF-8468-4C2B-8218-7EB460C180C8

Q30422206-3AF53264-BF63-4F75-98DF-D0BEE1B7418D

Q30422206-3B464765-8F10-4433-A998-30BF4883B58B

Q30422206-4BD609C3-D192-4523-A4E1-51FFC2BC3082

Q30422206-57A3C04E-3A8C-4F3A-B366-FC53EF530E6E

Q30422206-5962DC19-9809-467A-A5EA-507D7224C474

P2888

Q30422206-57FC4D86-C604-48B8-84A0-B2932966C96C

P304

Q30422206-33FC185C-ACE7-4B7A-BA0F-D17964C1CE88

P31

Q30422206-3DDB961D-D86C-4F18-B7F0-78A9AEDE5FC0

P356

Q30422206-90E042FD-D8F8-42C4-9E04-B9CB4E0E8C94

P433

Q30422206-3DCC9807-FCFF-4DDC-A2A3-452926780CB7

P478

Q30422206-0F71B28D-44ED-4EBF-91EA-93E54BF3DDB9

P50

Q30422206-02865115-0AD5-431F-B804-CA6368DD54F0

Q30422206-24E7C8F9-FF12-40A0-A720-E23CABDFF106

Q30422206-418DB685-0B05-4039-9DC7-F33D84293A39

Q30422206-5404074E-5904-4EA2-977A-5B786C0498EF

Q30422206-C6DAE43E-7FC3-47C8-8679-64371090C4AB

P577

Q30422206-FF1AC9E9-C26F-40A9-94D6-76BAE45F8510

P5875

Q30422206-DED7441C-6A06-46C7-8199-B685F14FDE3B

P6179

Q30422206-47BABFA3-0D9C-4843-9C06-2608ABAC8F9D

P698

Q30422206-421F7E81-DB5A-42F3-A601-60702DFD2953

P921

Q30422206-EE98D367-2B57-4C36-AD3B-ACD6B4B670CB

P932

Q30422206-7A6D8D5E-EA7C-42E3-94F5-804A2C5E52C1

P356

S13539-012-0079-1

P1433

Journal of Cachexia, Sarcopenia and Muscle

P1476

Serum creatinine as a marker o ...... tudy and review of literature.

@en

P2093

Deborah Benner

http://www.w3.org/2001/XMLSchema#string

John A Tayek

http://www.w3.org/2001/XMLSchema#string

Nazanin Noori

http://www.w3.org/2001/XMLSchema#string

Sapna S Patel

http://www.w3.org/2001/XMLSchema#string

Steven Heymsfield

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain

Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients.

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

Plasma gelsolin depletion and circulating actin in sepsis: a pilot study.

Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients

Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study

Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study

Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis.

Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.

P2888

s13539-012-0079-1

P304

19-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13539-012-0079-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Miklos Z Molnar

Csaba P. Kovesdy

Kamyar Kalantar-Zadeh

P577

2012-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229014299

http://www.w3.org/2001/XMLSchema#string

P6179

1042642425

http://www.w3.org/2001/XMLSchema#string

P698

22777757

http://www.w3.org/2001/XMLSchema#string

P921

1-methyl histidine (L-form)

P932

3581614

http://www.w3.org/2001/XMLSchema#string